Bobur Kholikov/LinkedIn
Oct 7, 2025, 13:06
Bobur Kholikov on iFlash Thrombosis Panel – D-Dimer
Bobur Kholikov, Regional Sales Manager at YHLO, shared a post on LinkedIn:
”iFlash Thrombosis Panel – D-Dimer
D-Dimer is a key biomarker of fibrin degradation, widely used to rule out or confirm thrombosis-related conditions. Elevated levels indicate active clot formation and breakdown, making it a crucial marker in emergency and routine care.
Clinical Value
- Excludes venous thromboembolism (VTE) with high negative predictive value
- Supports diagnosis of DVT, PE, and DIC
- Monitoring of anticoagulant therapy effectiveness
With the iFlash Thrombosis Panel, YHLO provides clinicians with reliable insights into coagulation and fibrinolysis, enhancing early intervention and improving patient outcomes.
Together, make a difference.”
Stay updated with Hemostasis Today.
-
Jan 12, 2026, 04:51Coronary Microvascular Dysfunction and HFpEF․ Prognostic Importance and Therapeutic Insights
-
Jan 12, 2026, 04:16Wolfgang Miesbach on VTE and Cancer: A 20-Year Signal That Can’t Be Ignored
-
Jan 12, 2026, 03:54Francine Freitas Fernandes on Transvaginal US for Pelvic Venous Disorders
-
Jan 12, 2026, 02:58Jara Garcia Ugaldebere Shares STORM-PE Results: Thrombectomy Plus Anticoagulation for Acute High-Risk PE
-
Jan 12, 2026, 02:54Discover the New Blood Project․ Enhanced Search, Browsing, and Learning Resources
-
Jan 12, 2026, 02:54Can Preoperative Iron Status Predict Severe Anemia After Bariatric Surgery?
-
Jan 12, 2026, 02:27Bryce Kerlin to Impact of Advanced Hemostasis/Thrombosis Fellowship Training at Haemophilia Publication
-
Jan 12, 2026, 02:21Martin Haluzík on Compariosn of Cardiovascular Outcomes Between Semaglutide and Dulaglutide Therapies
-
Jan 12, 2026, 01:55Frank Weinz on State-of-the-Art Thromboembolism Prophylaxis